- Home
- IBRX vs IBP Comparison
IBRX vs IBP Comparison
Compare IBRX & IBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IBRX | IBP |
|---|---|---|
| Founded | 2014 | 1977 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Homebuilding |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.2B | 8.2B |
| IPO Year | 2015 | 2014 |
Fundamental Metrics
Financial Performance| Metric | IBRX | IBP |
|---|---|---|
| Price | $9.17 | $225.13 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 7 | 8 |
| Target Price | $12.57 | ★ $266.14 |
| AVG Volume (30 Days) | ★ 11.7M | 449.6K |
| Earning Date | 05-08-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 1.18% |
| EPS Growth | ★ 38.71 | 6.70 |
| EPS | N/A | ★ 1.29 |
| Revenue | $113,288,000.00 | ★ $2,970,800,000.00 |
| Revenue This Year | $88.59 | $1.96 |
| Revenue Next Year | $131.15 | $4.32 |
| P/E Ratio | ★ N/A | $173.70 |
| Revenue Growth | ★ 668.31 | 1.00 |
| 52 Week Low | $1.95 | $182.88 |
| 52 Week High | $12.43 | $349.00 |
Technical Indicators
Market Signals| Indicator | IBRX | IBP |
|---|---|---|
| Relative Strength Index (RSI) | 70.92 | 52.51 |
| Support Level | $6.69 | $195.46 |
| Resistance Level | $9.54 | $224.93 |
| Average True Range (ATR) | 0.55 | 9.47 |
| MACD | 0.23 | 3.63 |
| Stochastic Oscillator | 90.94 | 75.54 |
Price Performance
Historical ComparisonAbout IBRX ImmunityBio Inc.
ImmunityBio Inc is a biotechnology company focused on developing and commercializing next-generation immunotherapies designed to activate the patient's immune system and provide durable protection against cancer and infectious diseases. Its approach harnesses both the adaptive and innate immune systems with the Cancer BioShield platform. The platform is built around the proprietary IL-15 superagonist ANKTIVA (nogapendekin alfa inbakicept) and is supported by a portfolio that includes adenovirus-vectored vaccines, NK-cell therapies, and additional immunomodulators. The company operates in the United States and Europe, with the majority of its revenue coming from the United States.
About IBP Installed Building Products Inc.
Installed Building Products Inc is an insulation installer serving the residential new construction market and are also a diversified installer of complementary building products, including waterproofing, fire-stopping and fireproofing, garage doors, rain gutters, window blinds, shower doors, closet shelving, mirrors and other products throughout the United States. The company installs fiberglass insulation, spray foam insulation, and cellulose insulation. The company has three operating segments consisting of Installation, Manufacturing and Distribution operations. Majority of revenue is derived from Installation segment.